Mercadolibre Inc vs Teladoc Health Inc — how do they compare? Mercadolibre Inc trades at $1,889.85 (market cap $94.13B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: Mercadolibre Inc is far larger — about 93.2× Teladoc Health Inc's market cap, and Mercadolibre Inc is trading nearer its 52-week high, Teladoc Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Mercadolibre Inc for 117 Days and Teladoc Health Inc for 39 Days on average.
| MELI | TDOC | |
|---|---|---|
Market Cap | $94.13B | $1.01B |
Volume | 273,781 | 4,668,477 |
Sector | Consumer Cyclical | Health |
52-Week High | $2.36K | $9.72 |
52-Week Low | $1.55K | $4.47 |
Typical Hold Time | 117 Days | 39 Days |
Enterprise Value | $101.77B | $1.27B |
Signals from Pluang's Aura AI — not financial advice
MercadoLibre (MELI) trades at $1,856.66, down 0.86% on the day, with the stock showing strong fundamental growth despite recent earnings volatility. The company maintains robust revenue expansion, reaching $28.89 billion in 2025, while technical indicators show a bullish trend with support at $1,842 and resistance at $1,870. Recent news highlights MercadoLibre's dominant position in Latin American e-commerce and fintech, with new service expansions in Brazil.
MELI presents a compelling growth story with strong analyst support (24 buy ratings, 0 sell) and a consensus price target of $2,170. However, investors face risks from profit margin compression and macroeconomic headwinds in key markets like Argentina, requiring careful monitoring of execution against high valuation multiples.
TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.
The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →